1. Executive Summary |
2. Latin America Sepsis Diagnostics Market Introduction |
2.1. Latin America Sepsis Diagnostics Market – Taxonomy |
2.2. Latin America Sepsis Diagnostics Market –Definitions |
2.2.1. Product |
2.2.2. Technology |
2.2.3. Pathogen |
2.2.4. Testing Type |
3. Latin America Sepsis Diagnostics Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Latin America Sepsis Diagnostics Market Dynamic Factors – Impact Analysis |
3.6. Latin America Sepsis Diagnostics Market – Competition Landscape |
4. Latin America Sepsis Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 |
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Latin America Sepsis Diagnostics Market, By Product, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.1. Instruments |
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Blood Culture Media |
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Assay Kits and Reagents |
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Software |
5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
6. Latin America Sepsis Diagnostics Market Forecast, By Technology, 2017-2021 and Forecast, 2020 – 2026 (Revenue, USD Mn) |
6.1. Microbiology |
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Molecular Diagnostics |
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Immunoassays |
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Flow Cytometry |
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7. Latin America Sepsis Diagnostics Market Forecast, By Pathogen, 2017-2021 and Forecast, 2020 – 2026 (Revenue, USD Mn) |
7.1. Bacterial Sepsis |
7.1.1. Gram-positive Bacteria |
7.1.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.1.3. Market Opportunity Analysis |
7.1.2. Gram-negative Bacteria |
7.1.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.2.3. Market Opportunity Analysis |
7.2. Fungal Sepsis |
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Others |
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8. Latin America Sepsis Diagnostics Market Forecast, By Testing Type, 2017-2021 and Forecast, 2020 – 2026 (Revenue, USD Mn) |
8.1. Laboratory Testing |
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. PoC Testing |
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
9. Latin America Sepsis Diagnostics Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
9.1. Brazil |
9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Mexico |
9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Argentina |
9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Rest of Latin America |
9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Latin America Sepsis Diagnostics Market – Opportunity Analysis Index, By Product, Technology, Pathogen, Testing Type and Country, 2022-2028 |
10. Brazil Perfusion Systems Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
10.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Blood Culture Media |
10.1.2. Assay Kits and Reagents |
10.1.3. Software |
10.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.2.1. Microbiology |
10.2.2. Molecular Diagnostics |
10.2.3. Immunoassays |
10.2.4. Flow Cytometry |
10.3. Pathogen Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Bacterial Sepsis |
10.3.1.1. Gram-positive Bacteria |
10.3.1.2. Gram-negative Bacteria |
10.3.2. Fungal Sepsis |
10.3.3. Others |
10.4. Testing Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.4.1. Laboratory Testing |
10.4.2. PoC Testing |
10.5. Brazil Perfusion Systems Market – Opportunity Analysis Index, By Product, Technology, Pathogen, Testing Type and Country, 2022-2028 |
10.6. Brazil Perfusion Systems Market Dynamics – Trends |
11. Mexico Perfusion Systems Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
11.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Blood Culture Media |
11.1.2. Assay Kits and Reagents |
11.1.3. Software |
11.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.2.1. Microbiology |
11.2.2. Molecular Diagnostics |
11.2.3. Immunoassays |
11.2.4. Flow Cytometry |
11.3. Pathogen Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Bacterial Sepsis |
11.3.1.1. Gram-positive Bacteria |
11.3.1.2. Gram-negative Bacteria |
11.3.2. Fungal Sepsis |
11.3.3. Others |
11.4. Testing Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.4.1. Laboratory Testing |
11.4.2. PoC Testing |
11.5. Mexico Perfusion Systems Market – Opportunity Analysis Index, By Product, Technology, Pathogen, Testing Type and Country, 2022-2028 |
11.6. Mexico Perfusion Systems Market Dynamics – Trends |
12. Argentina Perfusion Systems Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
12.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Blood Culture Media |
12.1.2. Assay Kits and Reagents |
12.1.3. Software |
12.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.2.1. Microbiology |
12.2.2. Molecular Diagnostics |
12.2.3. Immunoassays |
12.2.4. Flow Cytometry |
12.3. Pathogen Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Bacterial Sepsis |
12.3.1.1. Gram-positive Bacteria |
12.3.1.2. Gram-negative Bacteria |
12.3.2. Fungal Sepsis |
12.3.3. Others |
12.4. Testing Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Laboratory Testing |
12.4.2. PoC Testing |
12.5. Argentina Perfusion Systems Market – Opportunity Analysis Index, By Product, Technology, Pathogen, Testing Type and Country, 2022-2028 |
12.6. Argentina Perfusion Systems Market Dynamics – Trends |
13. Rest of Latin America Perfusion Systems Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
13.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Blood Culture Media |
13.1.2. Assay Kits and Reagents |
13.1.3. Software |
13.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.2.1. Microbiology |
13.2.2. Molecular Diagnostics |
13.2.3. Immunoassays |
13.2.4. Flow Cytometry |
13.3. Pathogen Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.3.1. Bacterial Sepsis |
13.3.1.1. Gram-positive Bacteria |
13.3.1.2. Gram-negative Bacteria |
13.3.2. Fungal Sepsis |
13.3.3. Others |
13.4. Testing Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Laboratory Testing |
13.4.2. PoC Testing |
13.5. Rest of Latin America Perfusion Systems Market – Opportunity Analysis Index, By Product, Technology, Pathogen, Testing Type and Country, 2022-2028 |
13.6. Rest of Latin America Perfusion Systems Market Dynamics – Trends |
14. Competition Landscape |
14.1. Strategic Dashboard of Top Market Players |
14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
14.2.1. Abbott Laboratories Inc. |
14.2.2. Beckman Coulter, Inc |
14.2.3. Becton, Dickinson, and Company |
14.2.4. BioMerieux SA |
14.2.5. Bruker Corporation |
14.2.6. Danaher Corporation |
14.2.7. Luminex |
14.2.8. Roche Diagnostics |
15. Research Methodology |
16. Key Assumptions and Acronyms |
Reviews
There are no reviews yet.